3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Gynecologic
1
Breast
1
Conditions
Breast Neoplasms
1215
Triple Negative Breast Neoplasms
283
Ovarian Neoplasms
262
Carcinoma, Non-Small-Cell Lung
248
Colorectal Neoplasms
189
Pancreatic Neoplasms
168
Stomach Neoplasms
164
Neoplasm Metastasis
156
Neoplasms
155
Lung Neoplasms
144
Prostatic Neoplasms
143
Melanoma
132
Carcinoma, Renal Cell
103
Squamous Cell Carcinoma of Head and Neck
102
Endometrial Neoplasms
99
Head and Neck Neoplasms
88
Colonic Neoplasms
82
Urinary Bladder Neoplasms
79
Uterine Cervical Neoplasms
77
Esophageal Neoplasms
76
Sarcoma
71
Breast Neoplasms, Male
68
Small Cell Lung Carcinoma
66
Carcinoma, Hepatocellular
60
Carcinoma, Ovarian Epithelial
58
Kidney Neoplasms
47
Carcinoma, Transitional Cell
41
Rectal Neoplasms
35
Fallopian Tube Neoplasms
34
Liver Neoplasms
32
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Pancreatic Intraductal Neoplasms
×
Breast
×
Clear all
NCT07213791
2026-06-04
FiREBOLT
Eli Lilly and Company
Phase 1
Recruiting
241 enrolled